Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-347-918-3531

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Gastrointestinal Stent Market Outlook

The global gastrointestinal stent market holds a valuation of US$ 455.44 Million by the end of the year 2022. Throughout the forecast period of 2023 to 2033, the market is likely to display growth at a CAGR of 5.5%, and is expected to hold a market value of around US$ 815.34 Million in 2033.

Market Outlook:

Data Points Market Insights
Market Value 2022 US$ 455.44 Million
Market Value 2023 US$ 476.72 Million
Market Value 2033 US$ 815.34 Million
CAGR 2023 to 2033 5.51%
Market Share of Top 5 Countries 65.3%
Key Market Players Boston Scientific Corporation, Hobbs Medical Inc., Taewoong Medical, Micro–Tech (Nanjing) Co., Ltd., Olympus Corporation, Merit Medical Systems, Qualimed, Medtronic, Conmed Corporation, Terumo Corporation, Johnson & Johnson Services, Inc., 3M, Smith & Nephew, Diagmed Healthcare, Medline Industries, Inc., Baxter, B. Braun Melsungen AG, Danaher Corporation, General Electric Company, Cantel Medical Corporation, ConvaTec Inc., and M.C. Johnson Company, Inc.

An artificial tube graft called gastrointestinal (GI) stent is put into the body to prevent obstructions in the stomach, oesophagus, and small intestine. It is an expandable metal or plastic mesh tube that is inserted into an anatomical duct to treat blockages brought on by malignant tissues in the bile ducts, oesophagus, intestine, or colon. It helps to eliminate the blockage and reduce the pressure caused by inflammation. A few of the most prevalent types of gastrointestinal stents are biliary, colonic, duodenal, esophageal, and pancreatic stents.

One of the main factors fuelling the market's expansion is the increased incidence of colorectal cancer in the world and rising geriatric population with gastrointestinal conditions such as diverticulosis, bowel disorders, and gastrointestinal cancers.

As per the World Health Organization (WHO), in 2020, colorectal cancer caused more than 1.9 million new cases and more than 930,000 deaths worldwide. By 2040, there will be 3.2 million new occurrences of colorectal cancer annually (an increase of 63%) and 1.6 million annual fatalities (an increase of 73%).

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Sales Analysis from 2017 to 2022 Vs Market Outlook for 2023 to 2033 for Gastrointestinal Stent Market

The gastrointestinal stent market expanded at a CAGR of 3.8% between 2017 and 2022 period due to numerous medical advancements and studies to upgrade diagnostic technologies, as well as the rise in demand for less invasive surgical treatments.

The global gastrointestinal stent contributed around 4.3% revenue share to the US$ 10.5 Billion gastrointestinal devices market in 2022.

Gastrointestinal stents are made to provide palliative care for a variety of illnesses that obstruct the GI tract. In the recanalization of gastrointestinal tumors and postoperative leak sealing, GI stents play a significant role. Drug–eluting devices, tissue modelling for benign conditions, and GI tract drainage/anastomosis are some additional potential uses for GI stents. The market for gastrointestinal stents is attributed to changing lifestyles and the rising incidence of GI cancers and other digestive diseases.

The stent manufacturers are also focusing on product development with the use of smart phone application and more market penetration for the product. Other factors expected to drive market growth include the implementation of advantageous government policies, significant expansion of healthcare infrastructure, and extensive research and development efforts, and increased focus by diagnostic laboratories on adoption of advanced technologies.

The increasing prevalence of cancer, growing demand for minimally invasive surgical procedures, development of advanced diagnostic technologies and rising disposable income, all these factors promotes the growth of global market over the forecast period.

H1–H2 Update

Market Statistics Details
Jan to Jun (H1), 2021 (A) 3.29%
Jul to Dec (H2), 2021 (A) 4.71%
Jan to Jun (H1),2022 Projected (P) 3.47%
Jan to Jun (H1),2022 Outlook (O) 3.73%
Jul to Dec (H2), 2022 Outlook (O) 4.81%
Jul to Dec (H2), 2022 Projected (P) 4.46%
Jan to Jun (H1), 2023 Projected (P) 4.25%
BPS Change : H1,2022 (O) - H1,2022 (P) 25 ↑
BPS Change : H1,2022 (O) - H1,2021 (A) 44 ↑
BPS Change: H2, 2022 (O) - H2, 2022 (P) 35 ↑
BPS Change: H2, 2022 (O) - H2, 2022 (A) 10 ↑
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

What are the Key Drivers for Players in the Gastrointestinal Stent Market?

One of the biggest causes of death around the globe is gastrointestinal cancer. Morbidity and mortality from chronic diseases like esophageal cancer, colorectal cancer, gastrointestinal digestive disorders, etc., have sharply increased in recent years.

According to statistics on cancer published in the International Journal of Cancer 2020, stomach cancer accounted for about 1.1 million new cases worldwide in 2020 and was the fourth leading cause of cancer death, accounting for about 800,000 deaths. It was also the fifth most common malignant tumor worldwide.

Companies have been manufacturing products like biodegradable stents made of biodegradable materials like polyester, polycarbonate, bacterially produced polymers etc. with the potential to elute drugs. Drug–stents can reduce lumen occlusion rates by delivering targeted drugs directly to tissue in addition to radial expansion to maintain luminal potency. As they progressively break down and are finally absorbed from the GI, biodegradable stents also aid in preserving the digestive tract's functionality for a certain period. Above factors are expected to boost market growth and provide lucrative opportunities to the players globally.

What are the Factors Restraining Demand for Gastrointestinal Stent Market?

Medical device approval regulations that are too strict will impede the market's expansion. The market growth rate will be further slowed down by unfavourable reimbursement circumstances in developing and underdeveloped economies along with stent–related complications. Biliary stents, as an example, exhibit early problems such as bleeding, infection, and pancreatitis. Esophageal stent therapy can cause painful foreign body symptoms and pulmonary aspiration as side effects.

The cost of healthcare has risen dramatically over the world in recent years, as have the prices of medical equipment. Healthcare providers and payers have limited financial means to spend on such a pricey surgery in developing nations like India and Brazil. In addition, Government in many Asian nations does not provide the healthcare coverage for endoscopic stenting treatments, which is one of the key reasons for patient and physician resistance to gastrointestinal stents. The absence of reimbursement in developing countries like India together with high product cost are expected to hinder the market growth in future.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Country–wise Insights

Country The USA
Market Share (2023) 41.9%
Market Share (2033) 43.7%
BPS Analysis 180
Country Germany
Market Share (2023) 7.5%
Market Share (2033) 8.2%
BPS Analysis 66
Country The United Kingdom
Market Share (2023) 6.2%
Market Share (2033) 5.8%
BPS Analysis –42
Country China
Market Share (2023) 4.7%
Market Share (2033) 4.5%
BPS Analysis –26
Country France
Market Share (2023) 4.7%
Market Share (2033) 4.4%
BPS Analysis –25

What is Driving the USA Market?

The USA will dominate the global market in 2023 with a market share of 41.9%.

Presence of large number of players, increasing cases of cancer, advantageous medical reimbursement policies, advanced levels of healthcare technologies, greater adoption of minimally invasive surgeries have made the U.S. market to dominate globally.

According to data from the American Cancer Society, nearly 43,030 new cases of rectal cancer and around 97,220 new cases of colon cancer were reported in 2018, and the number of cases have been increasing.

Why is the Germany Gastrointestinal Stent Industry Considered Lucrative?

Germany is set to hold a market share of 7.5% in 2023 within the global market.

In recent years, the role of stenting in the management of patients with digestive tract obstruction in Germany has expanded to include the oesophagus, stomach, small bowel, and colon. Recent technological advancements have improved stent patency and reduced stent–induced complications, resulting in a higher quality of life.

To avoid migration, a new device called Stentfix OTSC System has been developed in 2020. It is made up of a Nitinol clip that is preloaded on the applicator cap and is used to clip the flared end of FCSEMS (Fully Covered Self Expanding Metal Stent) to the gastrointestinal mucosal layer. Germany also has a large accessible medical facility, both of which are expected to increase demand for stents in the market.

What Makes the China Market Attractive?

The China market is set to hold around 4.7% revenue share in 2023 within the global market.

China market is increasing due to rising prevalence of gastrointestinal cancer and diseases. According to published report of 2022 in current oncology research article of MDPI publisher, reported upper gastrointestinal cancer incidences in China were 14,934,040 cases of male and 6,262,431 cases of female with growth rate 181.44% in between 1990 to 2019.

Another factor is the ongoing development of GI stents for various applications in order to expand treatment options and reduce complications.

  • For example, as per the article published in Journal of Thoracic Disease 2019, a Chinese study including 24 patients was conducted to understand the treatment option for refractory esophageal stenosis. The study involved use of self–expandable segmental stent- metallic and fully covered (SEMS). Following the result, stenting using SEMS proved out to be safe technological breakthrough, requiring minimal dilatation and resulting in lower morbidity and a higher quality of life

Category–wise Insights

Which Gastrointestinal Stent Product is Driving the Market Growth?

Biliary stent product sale will exhibit 43.5% of the global market share in 2023.

One of the main factors driving the growth of the biliary stents market is the rising prevalence of bile duct cancer, chronic liver disease, rising gallstones patients, technological advancement for devices, increasing geriatric population, and various surgical procedure to cure biliary diseases.

Which Material Type is Anticipated to Lead the Global Market?

Within the material category, self–expanding metal stent are expected to lead the global market with the market share of around 65.7% in 2023.

Factors responsible for the growth of this segment include an increase in demand for self–expanding metal stents due to benefits such as ease of insertion, reduced risk of dislodgment or migration, and extended patience

Which Application Segment is Expected to Rise at a High Rate in the Global Market?

The growing prevalence and occurrences of pancreatic cancers are responsible for the segment's growth with an expected market share of 27.6% in 2023 globally.

According to published report of the American Cancer Society's on pancreatic cancer statistics in 2023, 33,130 males and 30,920 females will be diagnosed with the disease in the USA Furthermore, pancreatic cancer accounts for about 3% of cancer cases and 7% of cancer–related deaths in the USA

Increasing the use of biodegradable stents for the treatment of pancreatic cancer, which results in good palliation for patients during their remaining life span with no serious risks or complications would drive market growth.

Which End User Segment is Forecasted to Dominate the Global Market?

In 2023, hospitals and clinics will dominate the global market with 63.5%.

The large share of this segment can be attributed to a large number of percutaneous transhepatic cholangiography (PTC) and endoscopic retrograde cholangiopancreatography (ERCP) procedures performed in hospital settings for various disease symptoms, increased government initiatives to provide standard gastrointestinal disease treatment and durable reimbursement scenarios.

Comparative View of Adjacent Gastrointestinal Stent Market

Gastrointestinal Stent Market:

Attributes Gastrointestinal Stent Market
CAGR (2023 to 2033) 5.5%
Market Value (2023) US$ 476.72 Million
Growth Factor Increased GI operation expenditure, rising GI cancer, and other digestive diseases prevalence, and increased preferences for minimally invasive surgeries
Key Market Trend Numerous medical advancements and studies to upgrade diagnostic technologies demand for less invasive surgical treatments.

Bioabsorbable Stents Market:

Attributes Bioabsorbable Stents Market
CAGR (2023 to 2033) 4.1%
Market Value (2023) US$ 172.3 Million
Growth Factor Rising prevalence of cardiovascular diseases and increased percutaneous coronary intervention procedures, and minimally invasive procedures
Key Trend A 3D printing technology is gaining traction; it is increasingly being used in the development of stents.

Gastrointestinal Rare Diseases Treatment Market:

Attributes Gastrointestinal Rare Diseases Treatment Market
CAGR (2023 to 2033) 3.6%
Market Value (2023) US$ 1.36 Billion
Growth Factor Increasing awareness of gastrointestinal diseases, the development of various medications, and government initiatives
Key Trend Technological advancements, rising research and development (R&D) expenditures for the development of novel medicines

Competitive Landscape

The gastrointestinal stent industry is moderately competitive, with several global and regional companies. The need for stents in gastrointestinal endoscopy increases as the prevalence of diseases connected with the gastrointestinal tract rises. As a result, most big corporations are adopting growth plans to reach out to emerging markets by new product launch.

  • In November 2021, Boston Scientific Corporation (US) received FDA and CE mark approval for its AdvanixTM Biliary Plastic Stents. These stents have been designed for treatment of benign biliary strictures, suspected and confirmed biliary malignancies and biliary stone disease. The product is now available in Europe and other international markets, and the company intends to launch it in the U. S. later in first quarter of 2022.
  • In October 2020, Olympus Corporation (Japan) introduced the HANAROSTENT stent, which comes in three different lengths such as 5 cm, 6 cm, and 7 cm. This is Esophagus TTS Self–expanding Metal Stents (SEMS) with anti–migration and precise placement capabilities, manufactured by Massachusetts Institute of Technology and marketed in the U. S. solely by Olympus Corporation.

Similarly, recent developments have been tracked by the team at Future Market Insights related to companies in the gastrointestinal stent market, which are available in the full report.

Report Scope as Per Gastrointestinal Stent Industry Analysis

Attribute Details
Forecast Period 2023 to 2033
Historical Data Available for 2017 to 2022
Market Analysis US$ Million for Value, and Units for Volume
Key Regions Covered North America, Latin America, Europe, East Asia, South Asia, Oceania, Middle East and Africa (MEA)
Key Countries Covered USA, Canada, Brazil, Mexico, Argentina, United Kingdom, Germany, Italy, France, Spain, Russia, BENELUX, China, Japan, South Korea, India, Indonesia, Malaysia, Thailand, Australia, New Zealand, GCC countries, Türkiye, South Africa and North Africa.
Key Market Segments Covered Product, Material, Application, End User, and Region
Key Companies Profiled
  • Boston Scientific Corporation
  • Hobbs Medical Inc.
  • Taewoong Medical
  • Micro–Tech (Nanjing) Co., Ltd.
  • Olympus Corporation
  • Merit Medical Systems
  • Qualimed
  • Medtronic
  • Conmed Corporation
  • Terumo Corporation
  • Johnson & Johnson Services, Inc.,
  • 3M
  • Smith & Nephew
  • Diagmed Healthcare
  • Medline Industries, Inc.
  • Baxter
  • B. Braun Melsungen AG
  • Danaher Corporation
  • General Electric Company
  • Cantel Medical Corporation
  • ConvaTec Inc.
  • M.C. Johnson Company, Inc.
Pricing Available upon Request

Key Market Segments Covered in Gastrointestinal Stent Industry Research

By Product:

  • Biliary Stents
  • Duodenal Stents
  • Colonic Stents
  • Pancreatic Stents
  • Esophageal Stents

By Material:

  • Self–Expanding Metal Stents
  • Plastic Stents

By Application:

  • Biliary Diseases
  • Irritable Bowel Syndrome
  • Gastrointestinal Cancers
  • Colorectal Cancer
  • Stomach Cancer
  • Esophageal Cancer
  • Pancreatic Cancer

By End User:

  • Hospitals and Clinics
  • Ambulatory Surgical Centers

By Region

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • The Middle East and Africa (MEA)

Frequently Asked Questions

What is the Growth Potential of the Gastrointestinal Stent Market?

The growth potential of the gastrointestinal stent market is 5.5% through 2033.

What Limits the Growth Potential of the Market?

The high cost of adoption is likely to limit market growth.

What is the United State’s Expected Share by 2033?

The United States is likely to capture a share of 43.7% by 2033.

How Big will the Market be in China by 2033?

The market in China will capture a share of 4.7% by 2033.

Which Country is Set to Register Exponential Growth in the Gastrointestinal Stent Market?

The United States, China, and the United Kingdom may witness significant growth in the market.

Table of Content

1. Executive Summary | Gastrointestinal Stent Market

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusions and Exclusions

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Market Innovation / Development Trends

4. Key Success Factors

    4.1. Product Adoption/Usage Analysis

    4.2. Key Promotional Strategies, by Manufacturers

    4.3. Key Regulations

    4.4. PESTEL Analysis

    4.5. Porter’s Analysis

    4.6. Disease Epidemiology

    4.7. Product Launch Activities

    4.8. Reimbursement Scenario

    4.9. Value Chain Analysis

5. Market Background

    5.1. Macro-Economic Factors

        5.1.1. Global GDP Growth Outlook

        5.1.2. Global Healthcare Outlook

        5.1.3. Global Gastrointestinal Devices Market Overview

    5.2. Forecast Factors - Relevance & Impact

        5.2.1. Top Companies Historical Growth

        5.2.2. New Product Launches and Approvals

        5.2.3. Growing incidence of Gastrointestinal Epidemiology

        5.2.4. R&D Expenditure by Key Players

        5.2.5. Historic and Current Revenue of key players

        5.2.6. Rising Consumer Awareness of the Product

        5.2.7. Rising Adoption of Device Technological development

        5.2.8. Strategic Developments by Key Players

        5.2.9. Increase Adoption of Gastrointestinal Care & Cancer Care for Various Materials

        5.2.10. Strategic Collaborations among Players

    5.3. Market Dynamics

        5.3.1. Drivers

        5.3.2. Restraints

        5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

    6.1. COVID-19 and Impact Analysis

        6.1.1. By Product

        6.1.2. By Material

        6.1.3. By Application

        6.1.4. By End User

        6.1.5. By Country

    6.2. 2022 Market Scenario

7. Global Market Volume (Units) Analysis 2017 to 2022 and Forecast, 2023 to 2033

    7.1. Historical Market Volume (Units) Analysis, 2017 to 2022

    7.2. Current and Future Market Volume (Units) Projections, 2023 to 2033

        7.2.1. Y-o-Y Growth Trend Analysis

8. Global Market - Pricing Analysis

    8.1. Regional Pricing Analysis By Material

    8.2. Pricing Break-up

        8.2.1. Manufacturer Level Pricing

        8.2.2. Distributor Level Pricing

    8.3. Global Average Pricing Analysis Benchmark

    8.4. Pricing Assumptions

9. Global Market Demand (in Value or Size in US$ Million) Analysis 2017 to 2022 and Forecast, 2023 to 2033

    9.1. Historical Market Value (US$ Million) and Volume (Units) Analysis, 2017 to 2022

    9.2. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033

        9.2.1. Y-o-Y Growth Trend Analysis

        9.2.2. Absolute $ Opportunity Analysis

10. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Million) and Volume (Units) Analysis by Product, 2017 to 2022

    10.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Product, 2023 to 2033

        10.3.1. Biliary Stents

        10.3.2. Duodenal Stents

        10.3.3. Colonic Stents

        10.3.4. Pancreatic Stents

        10.3.5. Esophageal Stents

    10.4. Market Attractiveness Analysis by Product

11. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Material

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Million) Analysis by Material, 2017 to 2022

    11.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Material, 2023 to 2033

        11.3.1. Self – Expanding Metal Stents

        11.3.2. Plastic Stents

    11.4. Market Attractiveness Analysis by Material

12. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Application

    12.1. Introduction / Key Findings

    12.2. Historical Market Size (US$ Million) Analysis by Application, 2017 to 2022

    12.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Application, 2023 to 2033

        12.3.1. Biliary Diseases

        12.3.2. Irritable Bowel Syndrome

        12.3.3. Gastrointestinal Cancers

        12.3.4. Colorectal Cancer

        12.3.5. Stomach Cancer

        12.3.6. Esophageal Cancer

        12.3.7. Pancreatic Cancer

    12.4. Market Attractiveness Analysis by Application

13. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By End User

    13.1. Introduction / Key Findings

    13.2. Historical Market Size (US$ Million) Analysis by End User, 2017 to 2022

    13.3. Current and Future Market Size (US$ Million) Analysis and Forecast by End User, 2023 to 2033

        13.3.1. Hospitals and Clinics

        13.3.2. Ambulatory Surgical Centers

    13.4. Market Attractiveness Analysis by End User

14. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region

    14.1. Introduction / Key Findings

    14.2. Historical Market Size (US$ Million) and Volume Analysis, by Region, 2017 to 2022

    14.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis Forecast by Region, 2023 to 2033

        14.3.1. North America

        14.3.2. Latin America

        14.3.3. Europe

        14.3.4. East Asia

        14.3.5. South Asia

        14.3.6. Oceania

        14.3.7. The Middle East & Africa

    14.4. Market Attractiveness Analysis by Region

15. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033

    15.1. Introduction

    15.2. Historical Market Size (US$ Million) and Volume (Units) Analysis by Market Taxonomy, 2017 to 2022

    15.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033

        15.3.1. By Country

            15.3.1.1. USA

            15.3.1.2. Canada

        15.3.2. By Product

        15.3.3. BY Application

        15.3.4. By Material

        15.3.5. By End User

    15.4. Market Attractiveness Analysis

        15.4.1. By Country

        15.4.2. By Product

        15.4.3. By Material

        15.4.4. By Application

        15.4.5. By End User

    15.5. Market Trends

    15.6. Key Market Participants - Intensity Mapping

    15.7. Drivers and Restraints - Impact Analysis

    15.8. Country Level Analysis & Forecast

        15.8.1. USA Market Analysis

            15.8.1.1. Introduction

            15.8.1.2. Market Analysis and Forecast by Market Taxonomy

                15.8.1.2.1. By Product

                15.8.1.2.2. By Material

                15.8.1.2.3. By Application

                15.8.1.2.4. By End User

        15.8.2. Canada Market Analysis

            15.8.2.1. Introduction

            15.8.2.2. Market Analysis and Forecast by Market Taxonomy

                15.8.2.2.1. By Product

                15.8.2.2.2. By Material

                15.8.2.2.3. By Application

                15.8.2.2.4. By End User

16. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033

    16.1. Introduction

    16.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022

    16.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033

        16.3.1. By Country

            16.3.1.1. Mexico

            16.3.1.2. Brazil

            16.3.1.3. Argentina

            16.3.1.4. Rest of Latin America

        16.3.2. By Product

        16.3.3. By Material

        16.3.4. By Application

        16.3.5. By End User

    16.4. Market Attractiveness Analysis

        16.4.1. By Country

        16.4.2. By Product

        16.4.3. By Material

        16.4.4. By Application

        16.4.5. By End User

    16.5. Market Trends

    16.6. Key Market Participants - Intensity Mapping

    16.7. Drivers and Restraints - Impact Analysis

    16.8. Country Level Analysis & Forecast

        16.8.1. Mexico Market Analysis

            16.8.1.1. Introduction

            16.8.1.2. Market Analysis and Forecast by Market Taxonomy

                16.8.1.2.1. By Product

                16.8.1.2.2. By Material

                16.8.1.2.3. By Application

                16.8.1.2.4. By End User

        16.8.2. Brazil Market Analysis

            16.8.2.1. Introduction

            16.8.2.2. Market Analysis and Forecast by Market Taxonomy

                16.8.2.2.1. By Product

                16.8.2.2.2. By Material

                16.8.2.2.3. By Application

                16.8.2.2.4. By End User

        16.8.3. Argentina Market Analysis

            16.8.3.1. Introduction

            16.8.3.2. Market Analysis and Forecast by Market Taxonomy

                16.8.3.2.1. By Product

                16.8.3.2.2. By Material

                16.8.3.2.3. By Application

                16.8.3.2.4. By End User

17. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033

    17.1. Introduction

    17.2. Historical Market Size (US$ Million) and Volume (Units) Analysis by Market Taxonomy, 2017 to 2022

    17.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033

        17.3.1. By Country

            17.3.1.1. Germany

            17.3.1.2. Italy

            17.3.1.3. France

            17.3.1.4. United Kingdom

            17.3.1.5. Spain

            17.3.1.6. BENELUX

            17.3.1.7. Russia

            17.3.1.8. Rest of Europe

        17.3.2. By Product

        17.3.3. By Material

        17.3.4. By Application

        17.3.5. By End User

    17.4. Market Attractiveness Analysis

        17.4.1. By Country

        17.4.2. By Product

        17.4.3. By Material

        17.4.4. By Application

        17.4.5. By End User

    17.5. Market Trends

    17.6. Key Market Participants - Intensity Mapping

    17.7. Drivers and Restraints - Impact Analysis

    17.8. Country Level Analysis & Forecast

        17.8.1. Germany Market Analysis

            17.8.1.1. Introduction

            17.8.1.2. Market Analysis and Forecast by Market Taxonomy

                17.8.1.2.1. By Product

                17.8.1.2.2. By Material

                17.8.1.2.3. By Application

                17.8.1.2.4. By End User

        17.8.2. Italy Market Analysis

            17.8.2.1. Introduction

            17.8.2.2. Market Analysis and Forecast by Market Taxonomy

                17.8.2.2.1. By Product

                17.8.2.2.2. By Material

                17.8.2.2.3. By Application

                17.8.2.2.4. By End User

        17.8.3. France Market Analysis

            17.8.3.1. Introduction

            17.8.3.2. Market Analysis and Forecast by Market Taxonomy

                17.8.3.2.1. By Product

                17.8.3.2.2. By Material

                17.8.3.2.3. By Application

                17.8.3.2.4. By End User

        17.8.4. United Kingdom Market Analysis

            17.8.4.1. Introduction

            17.8.4.2. Market Analysis and Forecast by Market Taxonomy

                17.8.4.2.1. By Product

                17.8.4.2.2. By Material

                17.8.4.2.3. By Application

                17.8.4.2.4. By End User

        17.8.5. Spain Market Analysis

            17.8.5.1. Introduction

            17.8.5.2. Market Analysis and Forecast by Market Taxonomy

                17.8.5.2.1. By Product

                17.8.5.2.2. By Material

                17.8.5.2.3. By Application

                17.8.5.2.4. By End User

        17.8.6. BENELUX Market Analysis

            17.8.6.1. Introduction

            17.8.6.2. Market Analysis and Forecast by Market Taxonomy

                17.8.6.2.1. By Product

                17.8.6.2.2. By Material

                17.8.6.2.3. By Application

                17.8.6.2.4. By End User

        17.8.7. Russia Market Analysis

            17.8.7.1. Introduction

            17.8.7.2. Market Analysis and Forecast by Market Taxonomy

                17.8.7.2.1. By Product

                17.8.7.2.2. By Material

                17.8.7.2.3. By Application

                17.8.7.2.4. By End User

18. East Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033

    18.1. Introduction

    18.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022

    18.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033

        18.3.1. By Country

            18.3.1.1. China

            18.3.1.2. Japan

            18.3.1.3. South Korea

        18.3.2. By Product

        18.3.3. By Material

        18.3.4. By Application

        18.3.5. By End User

    18.4. Market Attractiveness Analysis

        18.4.1. By Country

        18.4.2. By Product

        18.4.3. By Material

        18.4.4. By Application

        18.4.5. By End User

    18.5. Market Trends

    18.6. Key Market Participants - Intensity Mapping

    18.7. Drivers and Restraints - Impact Analysis

    18.8. Country Level Analysis & Forecast

        18.8.1. China Market Analysis

            18.8.1.1. Introduction

            18.8.1.2. Market Analysis and Forecast by Market Taxonomy

                18.8.1.2.1. By Product

                18.8.1.2.2. By Material

                18.8.1.2.3. By Application

                18.8.1.2.4. By End User

        18.8.2. Japan Market Analysis

            18.8.2.1. Introduction

            18.8.2.2. Market Analysis and Forecast by Market Taxonomy

                18.8.2.2.1. By Product

                18.8.2.2.2. By Material

                18.8.2.2.3. By Application

                18.8.2.2.4. By End User

        18.8.3. South Korea Market Analysis

            18.8.3.1. Introduction

            18.8.3.2. Market Analysis and Forecast by Market Taxonomy

                18.8.3.2.1. By Product

                18.8.3.2.2. By Material

                18.8.3.2.3. By Application

                18.8.3.2.4. By End User

19. South Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033

    19.1. Introduction

    19.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022

    19.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033

        19.3.1. By Country

            19.3.1.1. India

            19.3.1.2. Indonesia

            19.3.1.3. Malaysia

            19.3.1.4. Thailand

            19.3.1.5. Rest of South Asia

        19.3.2. By Product

        19.3.3. By Material

        19.3.4. By Application

        19.3.5. By End User

    19.4. Market Attractiveness Analysis

        19.4.1. By Country

        19.4.2. By Product

        19.4.3. By Material

        19.4.4. By Application

        19.4.5. By End User

    19.5. Market Trends

    19.6. Key Market Participants - Intensity Mapping

    19.7. Drivers and Restraints - Impact Analysis

    19.8. Country Level Analysis & Forecast

        19.8.1. India Market Analysis

            19.8.1.1. Introduction

            19.8.1.2. Market Analysis and Forecast by Market Taxonomy

                19.8.1.2.1. By Product

                19.8.1.2.2. By Material

                19.8.1.2.3. By Application

                19.8.1.2.4. By End User

        19.8.2. Indonesia Market Analysis

            19.8.2.1. Introduction

            19.8.2.2. Market Analysis and Forecast by Market Taxonomy

                19.8.2.2.1. By Product

                19.8.2.2.2. By Material

                19.8.2.2.3. By Application

                19.8.2.2.4. By End User

        19.8.3. Malaysia Market Analysis

            19.8.3.1. Introduction

            19.8.3.2. Market Analysis and Forecast by Market Taxonomy

                19.8.3.2.1. By Product

                19.8.3.2.2. By Material

                19.8.3.2.3. By Application

                19.8.3.2.4. By End User

        19.8.4. Thailand Market Analysis

            19.8.4.1. Introduction

            19.8.4.2. Market Analysis and Forecast by Market Taxonomy

                19.8.4.2.1. By Product

                19.8.4.2.2. By Material

                19.8.4.2.3. By Application

                19.8.4.2.4. By End User

20. Oceania Market 2017 to 2022 and Forecast 2023 to 2033

    20.1. Introduction

    20.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022

    20.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033

        20.3.1. By Country

            20.3.1.1. Australia

            20.3.1.2. New Zealand

        20.3.2. By Product

        20.3.3. By Material

        20.3.4. By Application

        20.3.5. By End User

    20.4. Market Attractiveness Analysis

        20.4.1. By Product

        20.4.2. By Material

        20.4.3. By Application

        20.4.4. By End User

    20.5. Market Trends

    20.6. Key Market Participants - Intensity Mapping

    20.7. Drivers and Restraints - Impact Analysis

    20.8. Country Level Analysis & Forecast

        20.8.1. Australia Market Analysis

            20.8.1.1. Introduction

            20.8.1.2. Market Analysis and Forecast by Market Taxonomy

                20.8.1.2.1. By Product

                20.8.1.2.2. By Material

                20.8.1.2.3. By Application

                20.8.1.2.4. By End User

        20.8.2. New Zealand Market Analysis

            20.8.2.1. Introduction

            20.8.2.2. Market Analysis and Forecast by Market Taxonomy

                20.8.2.2.1. By Product

                20.8.2.2.2. By Material

                20.8.2.2.3. By Application

                20.8.2.2.4. By End User

21. Middle East and Africa (MEA) Market Analysis 2017 to 2022 and Forecast 2023 to 2033

    21.1. Introduction

    21.2. Historical Market Size (US$ Million) and Volume (Units) Analysis by Market Taxonomy, 2017 to 2022

    21.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033

        21.3.1. By Country

            21.3.1.1. GCC Countries

            21.3.1.2. Türkiye

            21.3.1.3. North Africa

            21.3.1.4. South Africa

            21.3.1.5. Rest of Middle East and Africa

        21.3.2. By Product

        21.3.3. By Material

        21.3.4. By Application

        21.3.5. By End User

    21.4. Market Attractiveness Analysis

        21.4.1. By Country

        21.4.2. By Product

        21.4.3. By Material

        21.4.4. By Application

        21.4.5. By End User

    21.5. Market Trends

    21.6. Key Market Participants - Intensity Mapping

    21.7. Drivers and Restraints - Impact Analysis

    21.8. Country Level Analysis & Forecast

        21.8.1. GCC Countries Market Analysis

            21.8.1.1. Introduction

            21.8.1.2. Market Analysis and Forecast by Market Taxonomy

                21.8.1.2.1. By Product

                21.8.1.2.2. By Material

                21.8.1.2.3. By Application

                21.8.1.2.4. By End User

        21.8.2. Türkiye Market Analysis

            21.8.2.1. Introduction

            21.8.2.2. Market Analysis and Forecast by Market Taxonomy

                21.8.2.2.1. By Product

                21.8.2.2.2. By Material

                21.8.2.2.3. By Application

                21.8.2.2.4. By End User

        21.8.3. South Africa Market Analysis

            21.8.3.1. Introduction

            21.8.3.2. Market Analysis and Forecast by Market Taxonomy

                21.8.3.2.1. By Product

                21.8.3.2.2. By Material

                21.8.3.2.3. By Application

                21.8.3.2.4. By End User

        21.8.4. North Africa Market Analysis

            21.8.4.1. Introduction

            21.8.4.2. Market Analysis and Forecast by Market Taxonomy

                21.8.4.2.1. By Product

                21.8.4.2.2. By Material

                21.8.4.2.3. By Application

                21.8.4.2.4. By End User

22. Market Structure Analysis

    22.1. Market Analysis by Tier of Companies

    22.2. Market Share Analysis of Top Players

    22.3. Market Presence Analysis

23. Competition Analysis

    23.1. Competition Dashboard

    23.2. Competition Benchmarking

    23.3. Competition Deep Dive

        23.3.1. Boston Scientific Corporation

            23.3.1.1. Overview

            23.3.1.2. Product Portfolio

            23.3.1.3. Sales Footprint

            23.3.1.4. Key Financials

            23.3.1.5. SWOT Analysis

            23.3.1.6. Key Developments

            23.3.1.7. Strategy Overview

                23.3.1.7.1. Marketing Strategy

                23.3.1.7.2. Product Strategy

                23.3.1.7.3. Channel Strategy

        23.3.2. Hobbs Medical Inc.

            23.3.2.1. Overview

            23.3.2.2. Product Portfolio

            23.3.2.3. Sales Footprint

            23.3.2.4. Key Financials

            23.3.2.5. SWOT Analysis

            23.3.2.6. Key Developments

            23.3.2.7. Strategy Overview

                23.3.2.7.1. Marketing Strategy

                23.3.2.7.2. Product Strategy

                23.3.2.7.3. Channel Strategy

        23.3.3. Taewoong Medical

            23.3.3.1. Overview

            23.3.3.2. Product Portfolio

            23.3.3.3. Sales Footprint

            23.3.3.4. Key Financials

            23.3.3.5. SWOT Analysis

            23.3.3.6. Key Developments

            23.3.3.7. Strategy Overview

                23.3.3.7.1. Marketing Strategy

                23.3.3.7.2. Product Strategy

                23.3.3.7.3. Channel Strategy

        23.3.4. Micro-Tech (Nanjing) Co., Ltd.

            23.3.4.1. Overview

            23.3.4.2. Product Portfolio

            23.3.4.3. Sales Footprint

            23.3.4.4. Key Financials

            23.3.4.5. SWOT Analysis

            23.3.4.6. Key Developments

            23.3.4.7. Strategy Overview

                23.3.4.7.1. Marketing Strategy

                23.3.4.7.2. Product Strategy

                23.3.4.7.3. Channel Strategy

        23.3.5. Olympus Corporation

            23.3.5.1. Overview

            23.3.5.2. Product Portfolio

            23.3.5.3. Sales Footprint

            23.3.5.4. Key Financials

            23.3.5.5. SWOT Analysis

            23.3.5.6. Key Developments

            23.3.5.7. Strategy Overview

                23.3.5.7.1. Marketing Strategy

                23.3.5.7.2. Product Strategy

                23.3.5.7.3. Channel Strategy

        23.3.6. Merit Medical Systems

            23.3.6.1. Overview

            23.3.6.2. Product Portfolio

            23.3.6.3. Sales Footprint

            23.3.6.4. Key Financials

            23.3.6.5. SWOT Analysis

            23.3.6.6. Key Developments

            23.3.6.7. Strategy Overview

                23.3.6.7.1. Marketing Strategy

                23.3.6.7.2. Product Strategy

                23.3.6.7.3. Channel Strategy

        23.3.7. Qualimed

            23.3.7.1. Overview

            23.3.7.2. Product Portfolio

            23.3.7.3. Sales Footprint

            23.3.7.4. Key Financials

            23.3.7.5. SWOT Analysis

            23.3.7.6. Key Developments

            23.3.7.7. Strategy Overview

                23.3.7.7.1. Marketing Strategy

                23.3.7.7.2. Product Strategy

                23.3.7.7.3. Channel Strategy

        23.3.8. Medtronic

            23.3.8.1. Overview

            23.3.8.2. Product Portfolio

            23.3.8.3. Sales Footprint

            23.3.8.4. Key Financials

            23.3.8.5. SWOT Analysis

            23.3.8.6. Key Developments

            23.3.8.7. Strategy Overview

                23.3.8.7.1. Marketing Strategy

                23.3.8.7.2. Product Strategy

                23.3.8.7.3. Channel Strategy

        23.3.9. Conmed Corporation

            23.3.9.1. Overview

            23.3.9.2. Product Portfolio

            23.3.9.3. Sales Footprint

            23.3.9.4. Key Financials

            23.3.9.5. SWOT Analysis

            23.3.9.6. Key Developments

            23.3.9.7. Strategy Overview

                23.3.9.7.1. Marketing Strategy

                23.3.9.7.2. Product Strategy

                23.3.9.7.3. Channel Strategy

        23.3.10. Terumo Corporation

            23.3.10.1. Overview

            23.3.10.2. Product Portfolio

            23.3.10.3. Sales Footprint

            23.3.10.4. Key Financials

            23.3.10.5. SWOT Analysis

            23.3.10.6. Key Developments

            23.3.10.7. Strategy Overview

                23.3.10.7.1. Marketing Strategy

                23.3.10.7.2. Product Strategy

                23.3.10.7.3. Channel Strategy

        23.3.11. Johnson & Johnson Services, Inc.

            23.3.11.1. Overview

            23.3.11.2. Product Portfolio

            23.3.11.3. Sales Footprint

            23.3.11.4. Key Financials

            23.3.11.5. SWOT Analysis

            23.3.11.6. Key Developments

            23.3.11.7. Strategy Overview

                23.3.11.7.1. Marketing Strategy

                23.3.11.7.2. Product Strategy

                23.3.11.7.3. Channel Strategy

        23.3.12. 3M

            23.3.12.1. Overview

            23.3.12.2. Product Portfolio

            23.3.12.3. Sales Footprint

            23.3.12.4. Key Financials

            23.3.12.5. SWOT Analysis

            23.3.12.6. Key Developments

            23.3.12.7. Strategy Overview

                23.3.12.7.1. Marketing Strategy

                23.3.12.7.2. Product Strategy

                23.3.12.7.3. Channel Strategy

        23.3.13. Smith & Nephew

            23.3.13.1. Overview

            23.3.13.2. Product Portfolio

            23.3.13.3. Sales Footprint

            23.3.13.4. Key Financials

            23.3.13.5. SWOT Analysis

            23.3.13.6. Key Developments

            23.3.13.7. Strategy Overview

                23.3.13.7.1. Marketing Strategy

                23.3.13.7.2. Product Strategy

                23.3.13.7.3. Channel Strategy

        23.3.14. Diagmed Healthcare

            23.3.14.1. Overview

            23.3.14.2. Product Portfolio

            23.3.14.3. Sales Footprint

            23.3.14.4. Key Financials

            23.3.14.5. SWOT Analysis

            23.3.14.6. Key Developments

            23.3.14.7. Strategy Overview

                23.3.14.7.1. Marketing Strategy

                23.3.14.7.2. Product Strategy

                23.3.14.7.3. Channel Strategy

        23.3.15. Medline Industries, Inc.

            23.3.15.1. Overview

            23.3.15.2. Product Portfolio

            23.3.15.3. Sales Footprint

            23.3.15.4. Key Financials

            23.3.15.5. SWOT Analysis

            23.3.15.6. Key Developments

            23.3.15.7. Strategy Overview

                23.3.15.7.1. Marketing Strategy

                23.3.15.7.2. Product Strategy

                23.3.15.7.3. Channel Strategy

        23.3.16. Baxter

            23.3.16.1. Overview

            23.3.16.2. Product Portfolio

            23.3.16.3. Sales Footprint

            23.3.16.4. Key Financials

            23.3.16.5. SWOT Analysis

            23.3.16.6. Key Developments

            23.3.16.7. Strategy Overview

                23.3.16.7.1. Marketing Strategy

                23.3.16.7.2. Product Strategy

                23.3.16.7.3. Channel Strategy

        23.3.17. B. Braun Melsungen AG

            23.3.17.1. Overview

            23.3.17.2. Product Portfolio

            23.3.17.3. Sales Footprint

            23.3.17.4. Key Financials

            23.3.17.5. SWOT Analysis

            23.3.17.6. Key Developments

            23.3.17.7. Strategy Overview

                23.3.17.7.1. Marketing Strategy

                23.3.17.7.2. Product Strategy

                23.3.17.7.3. Channel Strategy

        23.3.18. Danaher Corporation

            23.3.18.1. Overview

            23.3.18.2. Product Portfolio

            23.3.18.3. Sales Footprint

            23.3.18.4. Key Financials

            23.3.18.5. SWOT Analysis

            23.3.18.6. Key Developments

            23.3.18.7. Strategy Overview

                23.3.18.7.1. Marketing Strategy

                23.3.18.7.2. Product Strategy

                23.3.18.7.3. Channel Strategy

        23.3.19. Cantel Medical Corporation

            23.3.19.1. Overview

            23.3.19.2. Product Portfolio

            23.3.19.3. Sales Footprint

            23.3.19.4. Key Financials

            23.3.19.5. SWOT Analysis

            23.3.19.6. Key Developments

            23.3.19.7. Strategy Overview

                23.3.19.7.1. Marketing Strategy

                23.3.19.7.2. Product Strategy

                23.3.19.7.3. Channel Strategy

        23.3.20. ConvaTec Inc.

            23.3.20.1. Overview

            23.3.20.2. Product Portfolio

            23.3.20.3. Sales Footprint

            23.3.20.4. Key Financials

            23.3.20.5. SWOT Analysis

            23.3.20.6. Key Developments

            23.3.20.7. Strategy Overview

                23.3.20.7.1. Marketing Strategy

                23.3.20.7.2. Product Strategy

                23.3.20.7.3. Channel Strategy

        23.3.21. M.C. Johnson Company, Inc.

            23.3.21.1. Overview

            23.3.21.2. Product Portfolio

            23.3.21.3. Sales Footprint

            23.3.21.4. Key Financials

            23.3.21.5. SWOT Analysis

            23.3.21.6. Key Developments

            23.3.21.7. Strategy Overview

                23.3.21.7.1. Marketing Strategy

                23.3.21.7.2. Product Strategy

                23.3.21.7.3. Channel Strategy

24. Assumptions and Acronyms Used

25. Research Methodology

Recommendations

Healthcare

Bioabsorbable Stents Market

Published : September 2023

Healthcare

Rare Gastrointestinal Diseases Treatment Market

Published : August 2023

Healthcare

Non-Vascular Stents Market

Published : October 2022

Explore Healthcare Insights

View Reports

Gastrointestinal Stent Market